Panel Cáncer de mama: | Estrógenos, Progesterona, Her-2neu, Ki67, E-cadherina, GATA3, Mamoglobina, GCDFP-15, Andrógenos, CK5/6, EGFR. |
Panel Cáncer cervicouterino: | p16, p40, PDL-1, CK AE1 / AE3 |
Panel Cáncer pulmonar: | TTF-1, Napsina A, CK 7, CK 20, p53. |
Panel Neoplasias gastrointestinales: | Inestabilidad Microsatélital (MLH1, PMS2, MSH2, MSH6), MUC 2, MUC 5a, E-Cadherina, CD117 (C-Kit) |
Panel Cáncer ginecológico: | Inestabilidad Microsatélital (MLH1, PMS2, MSH2, MSH6), Receptores de Estrógenos, Receptores de Progesterona, Inhibina, PAX8, p53 |
Panel Cáncer urológico: | SALL4, OCT3/4, Glypican, CD117, CD30, PLAP, AFP, Calretinina, CK 7, CK 20, AML, p64, p40, PDL-1, GATA 3, CK5/6, Racemasa |
Panel Cáncer Renal: | CK 7, CK 20, S100, Vimentina, CAIX, Racemasa, SDH, Kit, Pax 8, CD10, WT1 |
Panel Neoplasias de piel: | p16, p40, PDL-1, CK AE1 / AE3, Ki67, S100, SOX 10, MelanA, HMB45, PRAME |
Panel Neoplasias de tejidos blandos: | EMA, CKAE1/AE3, S100,AML, DESMINA, CD34, CD56, CD99, CD45, CKAE1/AE3, S100, HMB45, VIMENTINA, SALL4, NKX2.2 |
Panel Neoplasias linfoideas: | CD10, CD30, CD3, CD2, CD20, CD68, CD163, CD15, TdT, CD79a, BCL2, BCL6, CD23, CD11c, CD138, MUM1, IRTA1, Kappa, Lambda, Granzima, CD21, CD1a, CD207(Langerina), FASCINA, CD117, MPO, Glicoforin-A, CD41, CD43 |
Panel Tumores de Sistema Nervioso Central: | Proteína acido glial Fibrilar (GFAP), S100, SOX 10, ATRX, IDH, p53, Olig P53, EMA, D2-40, H3K21me3, Receptor de progesterona, Somatostatina 2a, STAt6, Brachiury, Inhibina. |
Panel Tumores neuroendocrinos: | Sinaptofisina, Cromogranina, CD56, Ki67, INSM1. |
Panel Primario desconocido: | CK7, CK 20, Receptores Hormonales Estrógeno y Progesterona TTF-1, PAX 8, Calretinina, D2-40, GATA3, WT1, Melan A, HMB-45, CDX2, SATB2, CK Ae1/AE3, Vimentina, Desmina, CD45, S100. |